Skip to main
PTLA
PTLA logo

Portola Pharmaceuticals (PTLA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Portola Pharmaceuticals (PTLA) Stock

About Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals LLC engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.
Market cap$1.42B
Today's volume
Revenue (TTM)
Avg. daily volume4.36M
EBITDA (TTM)
Open
Price / earnings ratio-4.78x
Today's range
Debt / equity
52 week range$5.31 - $31.73
5 year debt / equity112.25x
Beta (LTM)1.21x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 11, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 23, 2025, the market cap for PTLA stock is $1.42B

The current P/E ratio for PTLA stock is -4.78

The 52-week high for PTLA stock is $31.73. The current PTLA stock price $undefined is 100.00% below its 52-week high

The 52-week low for PTLA stock is $5.31. The current PTLA stock price $undefined has increased 100.00% from its 52-week low

No, the PTLA stock does not pay dividends to its shareholders

How to buy PTLA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PTLA stock

    Navigate to the Explore page. Then, type PTLA into the search bar. When you see PTLA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PTLA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Portola Pharmaceuticals Stock Earnings

The value each PTLA share was expected to gain vs. the value that each PTLA share actually gained.

Portola Pharmaceuticals (PTLA) reported Q1 2020 earnings per share (EPS) of -$0.88, missing estimates of -$0.80 by 10.00%. In the same quarter last year, Portola Pharmaceuticals's earnings per share (EPS) was $0. Portola Pharmaceuticals is expected to release next earnings on 05/11/2020, with an earnings per share (EPS) estimate of $0.

Buy Portola Pharmaceuticals (PTLA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.